Aminophylline
Cat.No:IA0240 Solarbio
CAS:317-34-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Metabolic Enzyme & Protease >
AminophyllineCAS:317-34-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 317-34-0 |
Name | Aminophylline |
Molecular Formula | C16H24N10O4 |
Molecular Weight | 420.43 |
Solubility | Soluble in Water/DMSO ≥5mg/mL |
Purity | HPLC≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 206-264-5 |
MDL | MFCD00013221 |
SMILES | O=C(N1C)N(C)C2=C(N=CN2)C1=O.O=C(N3C)N(C)C4=C(N=CN4)C3=O.NCCN |
InChIKey | FQPFAHBPWDRTLU-UHFFFAOYSA-N |
InChI | InChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2 |
PubChem CID | 9433 |
Target Point | Phosphodiesterase (PDE) |
Passage | Metabolic Enzyme&Protease |
Background | Aminophylline is a competitive non-selective phosphodiesterase inhibitor. |
Biological Activity | Aminophylline is a competitive nonselective phosphodiesterase inhibitor giving a bronchodilatory effect.[1] |
Data Literature Source | [1]. Hirota K,et al. Acta Anaesthesiol Scand. 2002 Mar;46(3):297-302. |
Unit | Bottle |
Specification | 500mg 1g |
Aminophylline是竞争性非选择性磷酸二酯酶抑制剂。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sinigrin Enhanced Antiasthmatic Effects of Beta Adrenergic Receptors Agonists by Regulating cAMP-Mediated Pathways
Click to check >>Author:Chu S. Liu W. Lu Y. Yan M. Guo Y. Chang N. Jiang M
IF:5.3310
Publish_to:Front Pharmacol
PMID:32508648